US 12,144,821 B1
Selective 3-prenyl 5-methyl ether, 7-o-rhamnoside flavone for the treatment of hepatic cancer
Peramaiyan Rajendran, Al-Ahsa (SA); Lalitha Keddal Govindaram, Madurai (IN); Basem M. Abdallah, Al-Ahsa (SA); Rajkapoor Balasubramanian, Namakkal (IN); and Enas M. Ali, Al-Ahsa (SA)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Feb. 2, 2024, as Appl. No. 18/431,303.
Int. Cl. A61K 31/7048 (2006.01); A61P 35/00 (2006.01)
CPC A61K 31/7048 (2013.01) [A61P 35/00 (2018.01)] 7 Claims
 
1. A method of treating cancer in a subject, the method comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising an effective amount of an apigenin 3-prenyl 5-methyl ether, 7-O-rhamnoside having the formula I:

OG Complex Work Unit Chemistry
and a pharmaceutically acceptable carrier.